Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.
Semin Cancer Biol. 2010 Aug;20(4):246-53. doi: 10.1016/j.semcancer.2010.05.005. Epub 2010 May 26.
Malignancy results from a complex combination of genetic and epigenetic changes, the full effects of which are still largely unknown. Here we summarize current knowledge of the origin, retrotranspositional activity, epigenetic state, and transcription of human endogenous retroviruses (HERVs), and then discuss the potential effects of their deregulation in cancer. Evidence suggests that cancer-associated epigenetic changes most likely underlie potential HERV-mediated effects on genome and transcriptome instability and may play a role in malignancy. Despite our currently limited understanding of the importance of HERVs or other transposable elements in cancer development, we believe that the emerging era of high-throughput sequencing of cancer genomes, epigenomes, and transcriptomes will provide unprecedented opportunities to investigate these roles in the future.
恶性肿瘤是遗传和表观遗传改变复杂组合的结果,其全部影响在很大程度上仍然未知。在这里,我们总结了人类内源性逆转录病毒(HERV)的起源、逆转录转座活性、表观遗传状态和转录的现有知识,然后讨论了它们在癌症中失调的潜在影响。有证据表明,与癌症相关的表观遗传变化很可能是 HERV 对基因组和转录组不稳定性产生潜在影响的基础,并且可能在恶性肿瘤中发挥作用。尽管我们目前对 HERV 或其他转座元件在癌症发展中的重要性的了解有限,但我们相信,癌症基因组、表观基因组和转录组高通量测序的崭新时代将为未来研究这些作用提供前所未有的机会。